Inventor
DEVERAUX QUINN
US32 patents
⚠️ This page may combine multiple inventors who share the name “DEVERAUX QUINN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INHIBRX INC
16 patentsUS10526397B2Jan 7, 2020
Non-immunogenic single domain antibodies
INHIBRX INC10 citations84
US11866507B2Jan 9, 2024
Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same
INHIBRX INC8 citations83
US10730929B2Aug 4, 2020
Serpin fusion polypeptides and methods of use thereof
INHIBRX INC5 citations83
US10723785B2Jul 28, 2020
Serpin fusion polypeptides and methods of use thereof
INHIBRX INC9 citations83
US10501551B2Dec 10, 2019
Multivalent and multispecific 41BB-binding fusion proteins
INHIBRX INC7 citations80
US10308720B2Jun 4, 2019
Multivalent and multispecific DR5-binding fusion proteins
INHIBRX INC3 citations71
US10093742B2Oct 9, 2018
Multispecific GITR-binding fusion proteins and methods of use thereof
INHIBRX INC4 citations71
US11117972B2Sep 14, 2021
Multivalent and multispecific OX40-binding fusion proteins
INHIBRX INC2 citations69
US11976126B2May 7, 2024
Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells
INHIBRX INC0 citations61
US11965017B2Apr 23, 2024
Serpin fusion polypeptides and methods of use thereof
INHIBRX INC0 citations61
US11827691B2Nov 28, 2023
Serpin fusion polypeptides and methods of use thereof
INHIBRX INC0 citations61
US11117973B2Sep 14, 2021
Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms
INHIBRX INC0 citations61
US11566078B2Jan 31, 2023
PDL1-binding proteins
INHIBRX INC0 citations59
US10745466B2Aug 18, 2020
Type III secretion system targeting molecules
INHIBRX INC0 citations51
US10344078B2Jul 9, 2019
Type III secretion system targeting molecules
INHIBRX INC0 citations51
US10844129B2Nov 24, 2020
Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids
INHIBRX INC0 citations50
INHIBRX LLC
3 patentsUS9045541B2Jun 2, 2015
CD47 antibodies and methods of use thereof
INHIBRX LLC78 citations94
US9914765B2Mar 13, 2018
WAP domain fusion polypeptides and methods of use thereof
INHIBRX LLC10 citations82
US9920109B2Mar 20, 2018
Serpin fusion polypeptides and methods of purification thereof
INHIBRX LLC9 citations81
INHIBRX LP
3 patentsINHIBRX BIOSCIENCES INC
3 patentsUS12227584B2Feb 18, 2025
Multivalent and multispecific OX40-binding fusion proteins
INHIBRX BIOSCIENCES INC0 citations59
US12187804B2Jan 7, 2025
Multivalent and multispecific 41BB-binding proteins
INHIBRX BIOSCIENCES INC0 citations59
US12195533B2Jan 14, 2025
Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the same
INHIBRX BIOSCIENCES INC0 citations49
BURNHAM INST
2 patentsUS6228603B1May 8, 2001
Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity
BURNHAM INST32 citations92
US7192728B2Mar 20, 2007
Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity
BURNHAM INST4 citations73